Regulation of human erythrocyte Na+/N+ exchange by soluble and particulate guanylate cyclase

American Journal of Physiology - Cell Physiology

Volumn 271, Issue 5 40-5, 1996, Pages

  Petrov, Victor ^a   Lijnen, Paul ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

atrial natriuretic peptide; erythrocytes; guanosine 3',5' cyclic monophosphate

Indexed keywords

ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR DERIVATIVE; CYCLIC GMP; GUANYLATE CYCLASE; PROTON; SODIUM ION;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; HUMAN; HUMAN CELL; NATRIURESIS; PRIORITY JOURNAL; PROTON SODIUM EXCHANGE; VASCULAR SMOOTH MUSCLE;

EID: 0029805368     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.1996.271.5.c1556     Document Type: Article

References (37)

1. Ahn, H. S., W. Crim, B. Pitts, and E. J. Sybertz. Calcium-calmodulin-stimulated and cyclic-GMP-specific phosphodiesterases. Adv. Second Messenger Phosphoprotein Res. 25: 271-288, 1992.
2. Ballermann, B. J., R. B. Marala, and R. K. Sharma. Characterization and regulation by protein kinase C of renal glomerular atrial natriuretic peptide receptor-coupled guanylate cyclase. Biochem. Biophys. Res. Commun. 157: 755-761, 1988.
3. Benos, D. J. Amiloride: a molecular probe of sodium transport in tissues and cells. Am. J. Physiol. 242 (Cell Physiol. 11): C131-C145, 1982.
4. Böhme, E., R. Jung, and I. Mechler. Guanylate cyclase in human platelets. Methods Enzymol. 38: 199-202, 1974.
5. Brenner, B. M., B. J. Ballermann, M. E. Gunning, and M. L. Zeidel. Diverse biological actions of atrial natriuretic peptide. Physiol Rev. 70: 665-699, 1990.
6. Budzik, G. P., S. L. Firestone, E. N. Bush, P. J. Connoly, T. W. Rockway, V. K. Sarin, and W. H. Holleman. Divergence of analogs in smooth muscle cell cGMP response and aorta vasorelaxation: evidence for receptor subtypes. Biochem. Biophys. Res. Commun. 144: 422-431, 1987.
7. Butt, E., C. Nolte, S. Schulz, J. Beltman, J. A. Beavo, B. Jastorff, and U. Walter. Analysis of the functional role of cGMP-dependent protein kinase in intact human platelets using a specific activator. Biochem. Pharmacol. 43: 2591-2600, 1992.
8. + transport in the cultured renal epithelial cell line, LLK-PK1. Biochem. Biophys. Res. Commun. 134: 852-860, 1986.
9. Chang, C.-H., K. P. Kohse, B. Chang, M. Hirata, B. Jiang, J. E. Douglas, and F. Murad. Characterization of ATP-stimulated guanylate cyclase activation in rat lung membranes. Biochim. Biophys. Acta 1052: 159-165, 1990.
10. Chinkers, M., S. Sing, and D. L. Garbers. Adenine nucleotides are required for activation of rat atrial natriuretic peptide receptor/guanylyl cyclase expressed in a baculovirus system. J. Biol. Chem. 266: 4088-4093, 1991.
11. Clyman, R. J., A. S. Blasksin, V. C. Manganiello, and M. Vaughan. Oxygen tension influences cGMP levels in tissues. Proc. Natl. Acad. Sci. USA 72: 3883-3887, 1975.
12. 2+-ATPase activity. Hypertension Dallas 12: 428-433, 1988.
13. De Lean, A. Amiloride potentiates atrial natriuretic factor inhibitor action by increasing receptor binding in bovine adrenal zona glomerulosa. Life Sci. 39: 1109-1116, 1986.
14. + transport in human red cells: evidence for a Na/H-exchange system. J. Membr. Biol. 90: 21-28, 1986.
15. + fluxes in cultured vascular smooth muscle cells. J. Hypertens. 3, Suppl. 3: S297-S298, 1985.
16. + exchange through an amiloride-insensitive pathway. J. Gen. Physiol. 84: 565-584, 1984.
17. Gruetter, C. A., D. Y. Gruetter, J. E. Lyon, P. J. Kadowitz, and L. J. Ignarro. Relationship between cyclic guanosine 3′:5′-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin. J. Pharmacol. Exp. Ther. 219: 181-186, 1981.
18. + uptake in rabbit aorta. J. Pharmacol. Exp. Ther. 248: 991-996, 1989.
19. Idriss, S. D., R. B. Pilz, V. S. Sharma, and G. R. Boss. Studies on cytosolic guanylate cyclase from human placenta. Biochem. Biophys. Res. Commun. 183: 312-320, 1992.
20. Iwata, T., E. Hardee, E. D. Frohlich, and F. E. Cole. Amiloride enhances atrial natriuretic factor stimulation of cGMP accumulation in rat glomeruli. Peptides 10: 575-579, 1988.
21. Katsube, N., K. Wakitani, K. F. Fok, F. S. Tjoeng, M. E. Zupec, S. R. Eubanks, S. P. Adams, and P. Needleman. Differential structure-activity relationships of atrial peptides as natriuretics and renal vasodilators in the dog. Biochem. Biophys. Res. Commun. 128: 325-330, 1985.
22. Leitman, D. C., J. W. Andresen, R. M. Catalane, S. A. Waldman, J. J. Tuan, and J. Murad. Atrial natriuretic peptide binding, cross-linking, and stimulation of cyclic GMP accumulation and particulate guanylate cyclase activity in cultured cells. J. Biol. Chem. 263: 3720-3728, 1988.
23. Marala, R. B., A. Sitaramayya, and R. K. Sharma. Dual regulation of atrial natriuretic factor-dependent guanylate cyclase activity by ATP. FEBS Lett. 281: 73-76, 1991.
24. Mülsch, A., A. Lückhoff, W. Pohl, and E. Bassenge. LY 83,583 (t-anilino-5,8-quinolinedione) blocks nitrovasodilator-induced cyclic GMP increases and inhibition of platelet activation. Naunyn-Schmiedeberg's Arch. Pharmacol. 340: 119-125, 1989.
25. O'Donnell, M. E., E. N. Bush, W. Holleman, and N. E. Owen. Biologically active atrial natriuretic peptides selectively activate Na/K/Cl cotransport in vascular smooth muscle cells. J. Pharmacol. Exp. Ther. 243: 822-828, 1987.
26. - cotransport in vascular smooth muscle cells. J. Biol. Chem. 261: 15461-15466, 1986.
27. + exchange decreases the affinity of sodium sites. Kidney Int. 46: 365-375, 1994.
28. Roubert, P., M. O. Lonchapt, P. E. Chabrier, P. Plas, J. Goulin, and P. Braquet. Down-regulation of atrial natriuretic factor receptors and correlation with cGMP stimulation in rat cultured vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 148: 61-67, 1987.
29. Schwartz, D., D. M. Geller, P. T. Manning, N. R. Siegel, K. M. Fok, C. E. Smith, and P. Needleman. Ser-Leu-Arg-Arg-atriopeptin III: the major circulating form of atrial peptide. Science Wash. DC 229: 397-400, 1985.
30. Sekar, M. C., and L. E. Hokin. Phosphoinositide metabolism and cGMP levels are not coupled to the muscarinic-cholinergic receptor in human erythrocyte. Life Sci. 39: 1257-1262, 1986.
31. Semrad, C. E., E. J. Cragoe, and B. J. Chang. Inhibition of Na/H exchange in avian intestine by atrial natriuretic factor. J. Clin. Invest. 8: 585-591, 1990.
32. Strom, T. M., J. Weil, and F. Bidlingmaier. Platelet receptors for atrial natriuretic peptide in man. Life Sci. 40: 769-773, 1987.
33. Tang, L. C., E. Schoomaker, and W. P. Weismann. Cholinergic agonists stimulate calcium uptake and cGMP formation in human erythrocytes. Biochim. Biophys. Acta 772: 235-238, 1984.
34. Tsutamoto, T., T. Kanamori, N. Morigami, Y. Sugimoto, O. Yamaoka, and M. Kinoshita. Possibility of downregulation of atrial natriuretic peptide receptor coupled to guanylate cyclase in peripheral vascular beds of patients with chronic severe heart failure. Circulation 87: 70-75, 1993.
35. Waldman, S. A., and F. Murad. Cyclic GMP synthesis and function. Pharmacol. Rev. 39: 163-196, 1987.
36. Zamir, N., S. Tuvia, R. River-Kreitman, S. Levin, and R. Korenstein. Atrial natriuretic peptide: direct effects on human red blood cell dynamics. Biochem. Biophys. Res. Commun. 188: 1003-1009, 1992.
37. Zhang, L.-M., H. Tao, and W. H. Newman. Regulation of atrial natriuretic peptide receptors in vascular smooth muscle cells: role of cGMP. Am. J. Physiol. 264 (Heart Circ. Physiol. 33): H1753-H1759, 1993.